Viyash Scientific Limited is an India-based integrated pharmaceutical company specializing in animal health products, including active pharmaceutical ingredients (APIs), finished dosage formulations, and analytical services. Formerly known as Sequent Scientific Limited until its rename in January 2026, it operates across key therapy areas such as anthelmintics, anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. The company maintains a global presence in over 100 countries across five continents, with manufacturing facilities in India, Turkey, Brazil, Spain, and Germany, and generates revenue primarily from Europe, Asia, and the rest of the world. Through subsidiaries like Alivira Animal Health, it distributes companion animal products and supports the pharmaceutical and life sciences industries with method validation, stability testing, and microbiology services. Ranked among the top 25 animal health companies worldwide, Viyash Scientific Limited employs over 3,000 people and focuses on quality-driven innovation in the pharmaceuticals and biotechnology sector.